Pharmacology, Toxicology and Pharmaceutical Science
Acinetobacter Baumannii
21%
Acute Myeloid Leukemia
11%
Antibiotic Therapy
15%
Antibiotics
28%
Antiinfective Agent
31%
Antimicrobial Resistance
14%
Atazanavir
17%
Bacterial Peritonitis
14%
Bloodstream Infection
100%
Carbapenem
34%
Case-Control Study
26%
Cefazolin
14%
Ciprofloxacin
13%
Clinical Feature
19%
Cohort Study
24%
Coronavirinae
47%
Enterobacter
11%
Escherichia coli
14%
Extended Spectrum Beta Lactamase
12%
Extrapulmonary Tuberculosis
11%
Gram Negative Bacterium
11%
HIV
71%
Human Immunodeficiency Virus Infection
17%
Hyperbilirubinemia
10%
Imipenem
15%
Klebsiella pneumoniae
25%
Lung Tuberculosis
14%
Methicillin Resistant Staphylococcus Aureus Infection
25%
Methicillin Susceptible Staphylococcus Aureus
21%
Methicillin-Resistant Staphylococcus Aureus
21%
Meticillin
15%
Middle East Respiratory Syndrome
11%
Mortality Rate
11%
Penicillinase
12%
Posaconazole
26%
Prevalence
48%
Retrospective Study
11%
SARS Coronavirus
30%
Serratia
11%
Serratia marcescens
11%
Smallpox Vaccine
11%
Spondylitis
22%
Staphylococcal Bacteremia
34%
Staphylococcal Infection
11%
Staphylococcus aureus
44%
Systemic Mycosis
14%
Third Generation Cephalosporin
12%
Vancomycin
37%
Voriconazole
14%
Zika Fever
11%
Medicine and Dentistry
Acquired Immune Deficiency Syndrome
14%
Antibiogram
21%
Antibiotic Therapy
14%
Antibiotics
11%
Antibody Response
14%
Antiinfective Agent
20%
Ascites
12%
Blood Culture
31%
Bloodstream Infection
70%
Case-Control Study
12%
Cellular Immunity
17%
Citrobacter Freundii
10%
Clinical Feature
14%
Clinical Guideline
14%
COVID-19
42%
Enzyme Linked Immunosorbent Assay
10%
Extended Spectrum Beta Lactamase
14%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
14%
Extrapulmonary Tuberculosis
19%
Highly Active Antiretroviral Therapy
14%
Human Immunodeficiency Virus
72%
Human Immunodeficiency Virus Infection
26%
In Vitro
10%
Influenza Vaccination
11%
Klebsiella pneumoniae
15%
Liver Cirrhosis
14%
Lung Tuberculosis
10%
Middle East Respiratory Syndrome
48%
Middle East Respiratory Syndrome Coronavirus
39%
Mortality Rate
12%
Odds Ratio
20%
Opportunistic Infection
15%
Prevalence
31%
Pseudomonas aeruginosa
10%
Retrospective Study
13%
Severe Acute Respiratory Syndrome Coronavirus 2
36%
Severe Fever with Thrombocytopenia Syndrome
11%
Smallpox
12%
Smallpox Vaccine
19%
Spondylitis
28%
Spontaneous Bacterial Peritonitis
25%
Sputum
12%
Staphylococcus Aureus
19%
T Cell
13%
Tertiary Care
15%
Vaccinia
12%
Vaccinia Virus
12%
Varicella Zoster Virus
11%
Vascular Endothelial Cell
11%
Zika Fever
11%
Immunology and Microbiology
Abscess
10%
Acinetobacter Baumannii
12%
Adoptive Immunity
30%
Antibiotic Sensitivity
22%
Antibody Response
30%
Antibody Titer
12%
Antimicrobial Resistance
10%
Blood Level
14%
C-Reactive Protein
16%
Carbapenem Resistant Enterobacteriaceae
8%
CD4 Lymphocyte Count
16%
Citrobacter Freundii
11%
Concentration Ratio
11%
Coronavirinae
16%
COVID-19
26%
Endolysin
8%
Enzyme-Linked Immunosorbent Assay
10%
Escherichia coli
15%
Gram-Negative Bacteria
13%
Human immunodeficiency virus
47%
Human Immunodeficiency Virus Infection
16%
Humoral Immunity
21%
Immune Reconstitution Inflammatory Syndrome
8%
Infectious Agent
13%
Influenza
11%
Inoculum
19%
Interferon Gamma
12%
Klebsiella pneumoniae
12%
Methicillin Susceptible Staphylococcus Aureus
31%
Methicillin-Resistant Staphylococcus Aureus
46%
Microorganism
15%
Middle East Respiratory Syndrome
11%
Middle East Respiratory Syndrome Coronavirus
31%
Minimum Inhibitory Concentration
19%
Mortality Rate
19%
Neutralizing Antibody
15%
Omicron Coronavirus Variant
9%
Opportunistic Infection
10%
Prevalence
20%
Seroconversion
9%
Severe Acute Respiratory Syndrome Coronavirus 2
34%
Smallpox
10%
Smallpox Vaccine
17%
Staphylococcus Aureus
57%
T Cell
11%
Vaccinia virus
13%
Vaccinium
12%
Vancomycin-Resistant Enterococcus
11%
Varicella Zoster Virus
9%
Vascular Endothelial Cell
14%